What do you reach for when a migraine hits: a pill, a dark room, or both? Most people with migraine end up trying a handful of medicines before they find a combination that fits their life. Some drugs stop an attack that’s already started. Others are taken on a schedule to make attacks happen less often. Knowing which is which, and what the evidence says about each, makes the whole process far less confusing.
This guide walks through the main categories of migraine medicine, the tradeoffs between them, and the practical mistakes that trip people up. It covers older standbys and newer options, and it flags where guidelines disagree. Nothing here replaces a conversation with a clinician, but it should make that conversation sharper.
Acute Medicine vs. Preventive Medicine: The Core Split
Every migraine treatment plan starts with one question: is this drug meant to stop an attack, or to prevent one? The answer shapes everything about how it’s used.
Acute (abortive) medicines are taken at the first sign of an attack. They aim to stop pain and associated symptoms like nausea and light sensitivity. Preventive (prophylactic) medicines are taken regularly, usually daily, whether or not a headache is present. They aim to reduce how often attacks occur and how severe they are.
The distinction matters because the two types are judged by different standards. An acute drug is a success if it kills a headache within two hours. A preventive drug is a success if it cuts attack frequency by roughly half over a few months. Mixing up the two leads to real problems, like taking a preventive drug only on bad days, which does nothing useful.
Preventives are usually considered when attacks are frequent (commonly four or more headache days a month), long, disabling, or hard to treat with acute medicine alone. Some people need both at once, and that’s normal.
Acute Treatments: What to Take When an Attack Starts
Acute options range from over-the-counter painkillers to drugs designed specifically for migraine. The choice depends on attack severity, how the person has responded before, and other health conditions. (4c hair)
Simple analgesics and combination products
For mild attacks, ordinary painkillers such as ibuprofen, aspirin, or paracetamol (acetaminophen) are often enough, especially when taken early. Caffeine-containing combination products are popular and can work, but they raise the overuse risk discussed below. A common mistake is waiting too long: these drugs work best in the first hour or so, before nausea and gastric slowdown make absorption unreliable.
Triptans
Triptans are the best-known migraine-specific acute drugs. Sumatriptan, the oldest, reached the market in the early 1990s and was approved in the United States in 1992. Others include rizatriptan, eletriptan, zolmitriptan, and almotriptan. They work on serotonin receptors and are generally recommended when simple painkillers fail or when attacks are moderate to severe.
Triptans have a genuine safety caveat. Because they constrict blood vessels, they are generally avoided in people with certain cardiovascular conditions, including coronary artery disease and uncontrolled high blood pressure. Anyone with heart or circulation concerns should raise them with a clinician before use. Triptans also come in different forms, including tablets, nasal sprays, and injections, and the fastest routes are not always the most convenient.
Gepants
Gepants are a newer class of acute drug that block the CGRP receptor rather than constricting vessels. Ubrogepant was approved by the US Food and Drug Administration in December 2019, and rimegepant followed in February 2020. Rimegepant was later also approved for prevention in May 2021, making it one of the few drugs with a dual role.
Gepants are often appealing to people who can’t take triptans for cardiovascular reasons. The tradeoff is usually cost and access, and long-term head-to-head comparisons with triptans are still maturing. It’s worth being skeptical of anyone who claims one class is universally better.
Lasmiditan
Lasmiditan is a ditan, approved in October 2019. It activates a different serotonin receptor subtype and does not cause vasoconstriction, so it offers another route for people who can’t use triptans. Its drawback is tolerability: dizziness and sedation are common, and people are typically told not to drive for a period after taking it. For some, that tradeoff is fine. For others, it’s a dealbreaker.
Antiemetics
Nausea is part of migraine for many people, and anti-sickness drugs are a legitimate part of acute treatment rather than an afterthought. They can also help the body absorb other medicines. Metoclopramide is a common choice; some antiemetics cause drowsiness, which can be welcome during an attack and inconvenient afterward.
Preventive Treatments: Reducing Attack Frequency Over Time
Preventives are a slower game. Most take weeks to show benefit, and the first choice is rarely the last. A practical rule: give a preventive a fair trial at an adequate dose before abandoning it, and change one thing at a time so you know what worked.
Established oral preventives
Several older drugs remain widely used and well studied:
| Drug class | Example | Notes |
|---|---|---|
| Beta-blockers | Propranolol | Long-established; useful when blood pressure or heart rate is also a concern |
| Anticonvulsants | Topiramate | Effective but can cause cognitive fog and tingling; dose is titrated slowly |
| Antidepressants | Amitriptyline | Often chosen when sleep is poor; sedation is a common side effect |
| Anticonvulsants | Valproate | Effective but contraindicated in pregnancy because of teratogenicity |
That last row deserves emphasis. Valproate carries serious pregnancy risks, and it should not be used by people who could become pregnant without a careful, explicit discussion. This is one of the clearest examples of why migraine treatment has to be individualized rather than copied from a friend’s prescription. (The row)
CGRP monoclonal antibodies
The CGRP monoclonal antibodies are injectable preventives that target CGRP or its receptor. Erenumab was approved in May 2018, fremanezumab and galcanezumab in September 2018, and eptinezumab in February 2020. They are given monthly or quarterly depending on the product, and they were designed specifically for migraine rather than borrowed from another condition.
For people who have failed several oral preventives, these can be genuinely transformative. They are also expensive, and access often depends on prior authorization and step therapy rules. Constipation is a commonly reported side effect with some of them.
Botulinum toxin and other options
Botulinum toxin injections are an established preventive for chronic migraine, generally meaning headaches on 15 or more days a month with migraine features on at least eight. Treatment is typically repeated every 12 weeks. Other options, including certain blood pressure drugs and supplements, appear in various guidelines with differing levels of support.
The Overuse Trap: When the Medicine Causes the Headache
Here’s the part people underestimate. Taking acute migraine medicine too often can cause medication-overuse headache, a chronic daily headache that persists because of the medicine rather than despite it. The third edition of the International Classification of Headache Disorders, published in 2018, sets thresholds that vary by drug class, commonly around 10 to 15 days a month depending on the medicine. The exact cutoffs differ between guidelines, so treat any single number as approximate.
The trap is sneaky. A person starts taking a painkiller two or three days a week, then four, and gradually the headaches become more frequent, so they take more medicine. The cycle feels like worsening disease when it’s partly the treatment. Breaking it usually means supervised withdrawal and a preventive strategy, which is uncomfortable but often effective.
Practical guardrails that help in real life:
- Track headache days and medicine days separately in a simple calendar or app.
- Agree on a monthly limit for acute drugs with a clinician before the pattern sets in.
- Flag any month where use creeps upward, even if headaches feel “worse.”
- Avoid combining multiple acute products on the same day without advice.
Practical Mistakes That Waste Time and Medicine
A few patterns show up again and again in real-world migraine care.
Taking acute medicine too late. Waiting to see if it’s “really a migraine” lets nausea and gastric stalling reduce absorption. Early treatment is generally more effective.
Expecting preventives to work immediately. Many people stop after two weeks because nothing changed. Most preventives need six to twelve weeks at a therapeutic dose.
Not matching the drug to the person. Someone with heart disease, someone planning pregnancy, and someone with frequent nausea need different plans. Copying a relative’s prescription is a common and avoidable error.
Ignoring triggers and lifestyle basics. Sleep regularity, hydration, caffeine consistency, and meal timing aren’t glamorous, but they influence how well any drug performs. Medicine works better on a stable foundation.
Skipping the headache diary. Without a record, it’s nearly impossible to tell whether a preventive is working or whether acute use is creeping toward overuse.
FAQ
What is the most common migraine medicine?
Simple painkillers like ibuprofen and paracetamol are the most widely used, followed by triptans for migraine-specific treatment. Which one is “right” depends on attack severity and the person’s health history. There is no single best drug for everyone. (2b hair)
Can I take migraine medicine every day?
Preventive medicines are designed for daily use. Acute medicines are not. Regular use of acute drugs, including triptans and simple painkillers, can cause medication-overuse headache, so most clinicians set a monthly limit on how often they are taken.
Are triptans safe for everyone?
No. Triptans are generally avoided in people with certain cardiovascular conditions, including coronary artery disease and uncontrolled high blood pressure, because they constrict blood vessels. People who can’t take them often have alternatives, including gepants and lasmiditan.
How long does a preventive medicine take to work?
Most preventives need several weeks to show benefit, and a fair trial is often six to twelve weeks at an adequate dose. Some people notice changes sooner, but judging a drug after a week or two usually leads to giving up too early.
What is the difference between a gepant and a triptan?
Both treat acute attacks, but they work differently. Triptans act on serotonin receptors and constrict blood vessels. Gepants block the CGRP receptor and do not constrict vessels, which makes them an option for some people who can’t use triptans. Cost and access often differ too.
Is migraine medicine safe during pregnancy?
It depends heavily on the drug. Valproate is contraindicated in pregnancy because of teratogenicity, and several other options require careful review. Anyone who is pregnant or could become pregnant should have their full regimen reviewed rather than adjusting doses alone.
Conclusion
Migraine medicine isn’t one decision; it’s a series of them. Acute drugs stop attacks, preventive drugs reduce how often they come, and the two are judged by completely different standards. The classes have expanded a lot since sumatriptan arrived in the early 1990s, with gepants, ditans, and CGRP antibodies now sitting alongside the older oral preventives. More choice is good news, but it also means more room for mismatches.
What actually works in practice is fairly unglamorous: treat early, give preventives a real trial, track days honestly, watch for overuse, and match the drug to the person rather than the label. Guidelines from different bodies don’t always agree on sequencing, and that’s fine, because the best plan is the one built around a specific person’s attacks, health history, and life. Start with a clear picture of the pattern, bring it to a clinician, and adjust from there. That approach beats hunting for a miracle pill every time.
The evidence base continues to evolve, and newer agents are being studied for both acute and preventive use. What matters most is not novelty but fit: a drug that suits one person’s attack pattern, cardiovascular history, and budget may be wrong for another. Ask about generic options, prior authorization support, and realistic expectations before starting anything new. If a treatment isn’t working after a fair trial, say so plainly and ask what the next step is. Migraine care rewards patience and honest record-keeping more than it rewards chasing the latest headline. With a clear plan and a clinician who listens, most people can reduce how much migraine controls their week.
